Funding

General Proximity

United States · Biotech · Healthtech

Develops induced proximity medicines targeting undruggable proteins across oncology and cardiometabolic disease

Visit generalproximity.bioFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Strategic$20MDaewoong Pharmaceutical — Role not disclosedFreeMind Investments — Role not disclosed

Investors

Daewoong PharmaceuticalStrategicFreeMind InvestmentsStrategic

Coverage

May 4, 2026General Proximity · Strategic

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesgeneralproximity.bio ↗